Brodimoprim
Systematic (IUPAC) name | |
---|---|
5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine | |
Clinical data | |
Identifiers | |
56518-41-3 | |
J01EA02 | |
PubChem | CID 68760 |
ChemSpider | 62004 |
UNII | V1YC7T6LLI |
KEGG | D07238 |
ChEMBL | CHEMBL31891 |
Chemical data | |
Formula | C13H15BrN4O2 |
339.188 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.
As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]
References
|